Trials / Unknown
UnknownNCT04647578
Physical Fitness Levels in Children and Adolescents With Chronic Inflammatory Bowel Disease (CIBD): Crohn's Disease, Ulcerative Colitis, Chronic Unclassified Colitis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- All
- Age
- 10 Years – 17 Years
- Healthy volunteers
- Accepted
Summary
Inflammatory bowel diseases (IBDs), including Crohn's disease (CD), ulcerative colitis (UC) and IBD-unclassified (IBD-U), are characterised by chronic inflammation of the gastrointestinal tract. Over the past 50 years, the incidence of IBD has increased globally, with the highest increase in industrialised countries. During the last 25 years, the incidence of IBD has increased dramatically among teenagers in northern France, with an increase of 126% and 156% for CD and UC, respectively. Physical fitness is a set of attributes related to a person's ability to perform physical activities that require aerobic capacity, endurance, strength or flexibility and is determined by a combination of regular physical activity and genetically inherited ability. Physical fitness, widely recognised as an important health determinant, plays an important role in growth and development. Due to the evidence-based importance of physical fitness for young people's health status, attention should be paid to the assessment of physical fitness at these ages and whatever the health status. At this time, there is no study on the assessment of physical fitness in IBD pediatric patient.
Conditions
- Crohn's Enteritis
- Crohn Disease
- Inflammatory Bowel Diseases
- Colitis, Ulcerative
- Granulomatous Enteritis
- Granulomatous Colitis
- Ileocolitis
- Proctocolitis
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GT3X Actigraph accelerometer. | GT3X Actigraph accelerometer during 7 days |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2024-07-01
- Completion
- 2024-07-01
- First posted
- 2020-12-01
- Last updated
- 2022-09-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04647578. Inclusion in this directory is not an endorsement.